Skip to content

Injury, inflammatory markers & the exacerbation of confusion: ASCRIBED

ASCRIBED: The impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in Dementia: a study in acute hip fracture patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN43803769
Enrollment
400
Registered
2017-05-11
Start date
2017-06-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia patients admitted to acute hospital settings with a hip fracture. Mental and Behavioural Disorders

Interventions

Participants due to have a hip fracture operation via spinal anaesthesia with all levels of pre-operative confusion (as assessed by clinical screening procedures, AMTS (England) and 4AT (Scotland)) wi

Sponsors

University of East Anglia
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Group 1: Pre-operative acute hip fracture patients with confusion as defined by the Abbreviated Mental Test (England) or 4AT (Scotland): Inclusion Criteria: 1. Patient must have had a confirmed proximal hip fracture requiring an operation and be aged 60 or older at the time of operation 2. Patient has a pre-operative Abbreviated Mental Test score of 8 or below or 4AT score of 1 or above 3. Patient must be undergoing spinal anaesthesia Group 2: Pre-operative acute hip fracture patients without confusion as defined by the Abbreviated Mental Test (England) or 4AT (Scotland): Inclusion Criteria: 1. Patient must have had a confirmed proximal hip fracture requiring an operation and be aged 60 or older at the time of operation 2. Pre-operative Abbreviated Mental Test score of 9 or above or 4AT score of 0 3. Patient must be undergoing spinal anaesthesia

Exclusion criteria

Exclusion criteria: Group 1 and 2: 1. Decision taken not to have hip surgery 2. Patient has head trauma with bleeding as indicated by a CT scan 3. Patient has confirmed diagnosis of Parkinson’s disease 4. Patient not expected to survive beyond 4 weeks

Design outcomes

Primary

MeasureTime frame
CSF inflammation and injury is measured by TNF-a, IL-1RA, IL-1ß, IL-6 and Neurogranin, tTau, Synaptotagmin, SNAP-25 at baseline.

Secondary

MeasureTime frame
Magnitude of the brain inflammation is measured by brain injury markers (phospho-Tau, NFL, neurogranin, synaptotagmin, SNAP-25) in CSF at baseline. Exploratory: 1. Higher levels of inflammatory and brain injury markers in CSF and blood are associated with worsening cognitive and functional decline measured by MMSE at 6 months post-operatively 2. Cytokines ratio CSF:blood pre-op time will show higher ratios in dementia than non-dementia patients measures in blood and CSF at baseline

Countries

England, Scotland, United Kingdom

Contacts

Public ContactSimon Hammond
s.hammond@uea.ac.uk+44 1603 591460

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 2, 2026